IRD Q2 2024 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$349M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-69.7% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$8M-748.9% margin

Net Income

-$8M-698.3% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

-35.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$806,000

Balance Sheet

Total Assets

$45M

Total Liabilities

$4M

Stockholders' Equity

$41M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$4M	-69.7%
Gross Profit	$1M	$4M	-69.7%
Operating Income	-$8M	-$5M	-54.5%
Net Income	-$8M	-$5M	-56.5%